Format

Send to

Choose Destination
Autophagy. 2015;11(5):844-6. doi: 10.1080/15548627.2015.1034420.

Oncogenic MAGEA-TRIM28 ubiquitin ligase downregulates autophagy by ubiquitinating and degrading AMPK in cancer.

Author information

1
a Departments of Physiology, Pharmacology, and Biochemistry; UT Southwestern ; Dallas , TX , USA.

Abstract

Autophagy is commonly altered in cancer and has a complicated, but important role in regulation of tumor growth. Autophagy is often tumor suppressive in the early stages of cancer development, but contributes to the late stages of tumor growth. Because of this, putative oncogenes that modulate autophagy signaling are especially interesting. Here we discuss our recent work detailing the function of the MAGEA-TRIM28 ubiquitin ligase as an oncogene product that targets PRKAA1/AMPKα1 for ubiquitination and proteasome-mediated degradation. Degradation of AMPK, a master cellular energy sensor and regulator, by MAGEA-TRIM28 results in significantly reduced autophagy and changes in cellular metabolism, including upregulation of MTOR signaling. Overall, expression of MAGEA3 (or MAGEA6) and degradation of AMPK is sufficient to induce transformation of normal cells and promote multiple hallmarks of cancer.

KEYWORDS:

AMPK; KAP1; MAGE; TRIM28; autophagy; cancer; melanoma-antigen; spermatogenesis; testis; ubiquitin

PMID:
25945414
PMCID:
PMC4509443
DOI:
10.1080/15548627.2015.1034420
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center